Muna Qayed
Pediatric Hematology-Oncology · Atlanta, GANPI 1508074568
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.5%), grants and speaking fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Incyte Corporation at 35.2% of the total. Among pediatric hematology-oncology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $1428.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$30K
- Vertex$14K
- Sanofi$11K
- Novartis$7K
- National Marrow Donor Program$7K
- Jazz Pharmaceuticals Inc.$5K
- plus $11K from 6 others
Across 80 payments — averaging $10,785 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$739K
- National Marrow Donor Program$36K
- Incyte Corporation$29K
- Pharmacyclics LLC, An Abbvie Company$22K
- Takeda Pharmaceuticals U.S.A., Inc.$20K
- Jazz Pharmaceuticals Inc.$15K
- plus $882 from 1 others
What the payments were for
- Consulting fees$44,15051%
- Speaking & faculty fees$4,4155%
- Grants$30,00035%
- Travel & lodging$4,1225%
- Food & beverage$3,0474%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 4 | $30,174 |
| Vertex | 12 | $14,306 |
| Sanofi | 7 | $10,906 |
| Novartis | 11 | $7,306 |
| National Marrow Donor Program | 11 | $6,963 |
| Jazz Pharmaceuticals Inc. | 2 | $5,250 |
| Sanofi-aventis U.S. LLC | 1 | $4,205 |
| Mesoblast, Inc. | 1 | $3,125 |
| Medexus Pharma, Inc. | 1 | $2,040 |
| Genentech USA, Inc. | 4 | $1,166 |
| Adaptive Biotechnologies Corporation | 5 | $218 |
| AstraZeneca | 1 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$85,733 in reported general payments places this provider in the 90th percentile of 74 pediatric hematology-oncology providers in Georgia.
See all pediatric hematology-oncology providers in Georgia →
Other pediatric hematology-oncology in Atlanta
- Robert SidonioAtlanta$834K
- Shannon MeeksAtlanta$255K
- Bhavya DoshiAtlanta$200K
- Shanmuganathan ChandrakasanAtlanta$67K
- Vivien SheehanAtlanta$51K
- Carlton DampierAtlanta$30K
- William CashAtlanta$28K
- Megan BrownAtlanta$24K
- Lakshmanan KrishnamurtiAtlanta$22K
- Carolyn BennettAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.